1Dean’s Office, University of California San Francisco, Fresno Medical Education Campus, San Francisco, CA.
2Department of Emergency Medicine, Wayne State University, Detroit, MI.
3Department of Surgery, Henry Ford Hospital, Wayne State University, Detroit, MI.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (http://journals.lww.com/ccmjournal).
Dr. Rivers currently conducts research for Abbott Laboratories, Alere, Spectral Diagnostics, and the National Institutes of Health. The early goal-directed therapy (EGDT) study was funded by the Henry Ford Hospital Fund for research and performed without extramural (academic or industry) funding. All catheters used and equipment in the study were paid for by Henry Ford Hospital to Edwards Lifesciences. Dr. Rivers received no compensation from industry during the conduct of the trial nor compensation for any intellectual properties related to this EGDT. Drs. Rivers and Jaehne received funding from the Henry Ford Health System. Dr. Coz-Yataco has disclosed that he does not have any potential conflicts of interest.
For information regarding this article, E-mail: email@example.com